ALL ARC TRIAL FAQS

If an enrolled patient fails non-operative treatment, can they be scheduled for surgery?

Yes. Appropriate follow-up care and treatment should be provided based on each individual patient’s needs and the determination of their treating physician. Ideally, patients randomized to non-operative treatment should wait 6 months before pursuing surgery, if possible, in order for the treatment to be fully effective. However, if, prior to the 6-month mark, the physician [...]

Can the patient switch treatments after beginning the study?

Yes. The patient is free to switch treatments at any time. However, ideally, patients are asked to stick with their assigned treatment for at least 6 months. If there are a significant number of patients who “cross over” within the first 6 months – operative patients who do not have surgery or nonoperative patients who [...]

What happens if a patient’s insurance company refuses to pay for surgery AFTER they have been randomized to the operative arm?

The study does not cover the cost of treatment, so the surgery would likely not be performed and this patient would become a “crossover.” While every effort should be made to avoid randomizing a patient whose insurance will not pay for treatment, once randomized – regardless of whether the assigned treatment is completed – a [...]

What if a patient’s insurance company limits the number of physical therapy visits it will cover?

There is a lot of flexibility in the physical therapy treatment protocols (for both postop & non-op) regarding how often a patient attends physical therapy. In consultation with their treating physical therapist, patients can customize the ratio of in-clinic physical therapy visits to home exercise days to fit their individual needs, schedule, and insurance coverage.

How soon does the patient need to start their assigned treatment?

Ideally, patients should begin treatment as soon as possible, but – at most – they should begin their assigned treatment within 2 months (8 weeks) after randomization. If a patient cannot begin treatment within 2 months, they could wait to enroll in the trial until they can begin treatment. Otherwise, it would be a protocol [...]

Go to Top